Press Release: SBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power

Dow Jones
Jul 01, 2025

IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical"), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer $(CMO.UK)$, effective July 1, 2025.

As CMO of SBC Medical, Mr. Inoue will lead efforts to enhance the brand value of the group's portfolio, including Shonan Beauty Clinic, one of Japan's largest aesthetic medical brands. He will also spearhead the evolution and optimization of the company's marketing infrastructure with a strong focus on digital innovation. Through strategic initiatives that address the increasing diversity of customer touchpoints, he will work to further strengthen the Group's global competitiveness and contribute to the sustainable advancement of the medical aesthetics industry.

Mr. Inoue began his career at P&G Japan and has since accumulated decades of experience in brand strategy, organizational management, and integrated marketing centered on digital at leading international companies both in Japan and overseas, including Eli Lilly Japan, Adobe, and KDDI. He is well recognized for his strengths in designing marketing processes and building organizations from a company-wide perspective, as well as his ability to consistently lead initiatives from research and strategy development to the establishment and operation of execution frameworks and various supporting environments. Most recently, he served as CMO at Pioneer Corporation, where he led the launch of the marketing organization, restructuring of the planning and communication areas, and drove the market introduction of new products. Additionally, he has been instrumental in supporting the development of next generation marketers through contributions to marketing publications, speaking at industry conferences, and collaborating with educational institutions.

   -- Comment from CEO Yoshiyuki Aikawa"We are delighted to welcome Mr. Shinya 
      Inoue as our new CMO. He brings exceptional expertise and a proven track 
      record in brand strategy, organizational development, and integrated 
      digital marketing. His leadership will be instrumental as we continue to 
      expand globally and elevate the value of our brand." 
   -- Comment from Shinya Inoue"I am truly honored to join SBC Medical at this 
      pivotal moment, as the company enters a new phase of growth following its 
      successful listing on Nasdaq last year. Since opening its first clinic in 
      Fujisawa in 2000, the company has remained steadfast in its commitment to 
      making aesthetic medicine more accessible guided by CEO Aikawa's vision. 
      By supporting customers in their desire to live confidently and 
      authentically, SBC has transformed medical aesthetics from a luxury into 
      a more approachable part of everyday life. As a member of this visionary 
      team, I am committed to leveraging my experience to help shape a 
      healthier, more transparent market and contribute to the continued 
      success of SBC Medical." 
   -- Career History: Shinya InoueApril 2004: Joined P&G JapanNovember 2008: 
      Joined Eli Lilly JapanApril 2010: Joined Adobe JapanMarch 2018: Joined 
      KDDI CorporationApril 2021: Joined Pioneer Corporation as CMO (Chief 
      Marketing Officer)July 2025: Joined SBC Medical as CMO (Chief Marketing 
      Officer) 

About SBC Medical

SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensing of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic's customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.

For more information, visit https://sbc-holdings.com/

Contact

SBC Medical Group Holdings Incorporated (Asia)

Hikaru Fukui / Head of Investor Relations E-mail: ir@sbc-holdings.com

Momoko Morita / Public Relations E-mail: pr@sbc.or.jp

ICR LLC (In the US)

Bill Zima / Managing Partner Email: bill.zima@icrinc.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/201c077c-41b2-4182-81ec-69c60713c013

(END) Dow Jones Newswires

July 01, 2025 08:00 ET (12:00 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10